ɬÀï·¬

Event Program

Wednesday, December 3

Ìý

  • 12:00 PM – 01:00 PM: REGISTRATION AND COFFEE
  • 01:00 PM – 01:15ÌýPM: OPENING REMARKS

Gerald Batist, MD.ÌýMember of the ɬÀï·¬ Centre for Translational Research and Associate Director of the Axe Experimental Therapies RRCancer.Ìý

  • 01:15ÌýPM – 02:40 PM: PANEL DISCUSSION 1 - THE VOICE OF THE PATIENT

Chair: Karine-IseultÌýIppersiel,ÌýPresident andÌýCEO of the Quebec Breast Cancer Foundation

Talk 1:ÌýValue Over Volume: Patient-Centered Approaches to Molecular Testing in Quebec Oncology
Eva Villalba, MBA, MSc. Executive Director, Quebec Cancer Coalition

Talk 2:ÌýWhen Genomics Gets Personal: A Scientist and Breast Cancer Patient Perspective
Catalina Lopez-Correa, PhD. Chief Global Strategy Officer at Genome Canada

Talk 3:ÌýTransforming Patient Care Through the Pragmatic Trials CollaboratoryÌýinÌýReal-world Practice
Nathalie Tremblay, PhD, Co-Founder and Board Director at C4Care – Consortium international de santé

Discussion and Q&A

  • 02:40 PM – 03:10 PM: COFFEE BREAK
  • 03:10 PM – 04:45ÌýPM: PANEL DISCUSSION 2 - BEYOND GENOMICS: THE ADVANCES OF MOLECULAR PROFILING

Chair: Philippe Lefrançois, MD.ÌýAssistant Professor at the Department of Medicine, ɬÀï·¬Ìý

Talk 1:ÌýÌýClinical and Translational Proteomics: Providing Decision-Making Information in Medicine
Christoph Borchers, PhD. Director of Segal Cancer Proteomics Centre and Full Professor at the Department of Oncology, ɬÀï·¬

Talk 2:ÌýModulating Immunotherapy Outcomes Through Fecal Microbiota Transplantation: Impacts on Response and Toxicity
Saman Maleki, PhD. Associate Professor at the Department of Oncology, Western University

Talk 3:ÌýAdvancing Microbiome-Based Cancer Therapies: From Bench-to-Bedside
Edmond Rafie, MD.Ìý Clinician-scientist Fellow at the CHUM Microbiome Centre, Centre hospitalier de l’Université de Montréal (CRCHUM).

Talk 4Ìý(Trainee Presentation):ÌýmiRNA Biomarkers Predicting Gemcitabine-docetaxel Response in LeiomyosarcomaÌý
Pegah Rahimizadeh, PhD Candidate,
RI-MUHC,ÌýɬÀï·¬

Discussion and Q&A

  • 04:45ÌýPM –06:45ÌýPM: NETWORKING COCKTAILÌýAND POSTER EXHIBITION

Ìý

Ìý

Thursday, December 4

Ìý

  • 07:30 AM – 03:30 PM: REGISTRATION AND COFFEE
  • 08:00 AM – 09:50 AM: PANEL DISCUSSION 3 - D2R: SHOWCASING RNA THERAPEUTIC APPLICATIONS

Chair: Michael Witcher, PhD. Assistant Professor at the Department of Oncology, ɬÀï·¬Ìý

Talk 1:ÌýÌýThe Jerry Pelletier Initiative: Diagnostic and Therapeutic Innovations for Rare CancersÌý
Yasser Riazalhosseini, PhD. Head of the Cancer Genomics program at the ɬÀï·¬ Genome Centre; Associate Professor at the Department of Human Genetics, ɬÀï·¬

Talk 2:ÌýRe-Heating the Immune-Cold Pancreas:Ìý Cancer Vaccines to Reprogram Pancreatic Tumor ImmunityÌýÌý
Kim Ma, MD. Assistant Professor at the Department of Oncology, ɬÀï·¬

Talk 3:ÌýRise of the vaccine trials: concept and practicality in lung and bladder cancer.Ìý
Ramy Saleh, MD, MSc. Associate Professor at the Department of Oncology, ɬÀï·¬

TalkÌý4 (Trainee Presentation):ÌýCRC Unplugged: Tracing NFE2L3 From Gut Microbiota to Colitis and Cancer
Anantpreet Kaur Sood, PhD Candidate, Lady Davis Institute, ɬÀï·¬

Discussion and Q&A

  • 09:50 AM – 10:20 AM: COMPLIMENTARY BREAKFAST & COFFEE BREAK
  • 10:20 AM – 11:45ÌýAM: PANEL DISCUSSION 4 - ADVANCES AND APPLICATIONS IN LIQUID BIOPSIES

Chair: Mark Basik, MD. Professor, Departments of Surgery and Oncology, ɬÀï·¬Ìý

Talk 1:ÌýAdvances In Liquid Biopsies at The Jewish General Hospital
Adriana Aguliar, PhD. Scientific Director of the Cancer Genomics and Translational Research Laboratory

Talk 2:ÌýWhole genome sequencing as a uniting force for cancer detection, diagnostics, and monitoring
Trevor Pugh, PhD. Director of Genomics Program & Senior Investigator, Ontario Institute for Cancer Research; Professor at Department of Medical Biophysics, University of Toronto

Talk 3Ìý(Trainee Presentation):ÌýDevelopment of a Second-Generation Diagnostic Test Based on Ganglioside Biomarkers for Early Detection of Ovarian Cancer
Migmar Tsamchoe, PhD.ÌýPost-Doc Fellow, Lady Davis Institute, ɬÀï·¬

Discussion and Q&A

  • 11:45ÌýAM – 12:45 PM: LUNCH BREAK
  • 12:45 PM – 01:45ÌýPM: POSTER EXHIBITION AND EVALUATION
  • 01:45ÌýPM – 03:10 PM: PANEL DISCUSSION 5 - AI IN CANCER PREDICTION AND TREATMENT

Chair: John Kildea, PhD. Associate Professor at the Department of Oncology, ɬÀï·¬Ìý

Talk 1:ÌýBuilding Digital Pathology AI Models for Cancer Detection and Prediction.
Anne Martel, PhD, Senior Scientist at Sunnybrook Research Institute; Professor at the Department of Medical Biophysics, University of Toront

Talk 2: Integrative topic modeling analysis of transcriptomes and pathology images
Yue Li, PhD,
Associate Professor at the School of Computer Science, ɬÀï·¬

Talk 3Ìý(Trainee Presentation):ÌýAssociation of Deep Learning-Derived Paraspinal Muscle Sarcopenia with Mortality in Head and Neck Cancer
Joshua Ron Onichino,ÌýMedical Student and Machine learning Intern,ÌýLady Davis Institute, ɬÀï·¬Ìý

Discussion and Q&A

  • 03:10 PM – 03:40 PM: COFFEE BREAK
  • 03:40 PM – 05:05 PM: PANEL DISCUSSION 6 - TRANSLATING DISCOVERIES INTO CLINICAL PRACTICE

Chair: Miriam Santos Dutra, PhD. Chief Operating Officer of ɬÀï·¬ Centre of Translational Research in Cancer at the Jewish General HospitalÌý

Talk 1:ÌýThe Translational Challenge: From Pipette to Patient
Denis Claude Roy, MD. Chief Scientific Officer of the C3i Centre; Chief Executive Officer at CellCAN, and Full Professor of Medicine, University of Montreal

Talk 2:ÌýFrom PhD to co-founder of a medical device company - Why I would do it again
Francois Therriault-Proulx, PhD,
Chief Executive Officer & Co-Founder at MedScint

Talk 3:ÌýÌýAccelerating Translation: AI-driven models and Consortium Approaches
ArmstrongÌýMurira, PhD,ÌýCo-Founder and CEO atÌýSimmunomeÌý

Discussion and Q&A

  • 05:05ÌýPM – 05:30ÌýPM: AWARD CEREMONY & CLOSING REMARKS

Gerald Batist, MD. Member of the ɬÀï·¬ Centre for Translational Research and Associate Director of the Axe Experimental Therapies RRCancer.Ìý

Back to top